Entity Common Stock, Shares Outstanding of Innovation1 Biotech Inc. from 30 Nov 2015 to 06 May 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Innovation1 Biotech Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Nov 2015 to 06 May 2025.
  • Innovation1 Biotech Inc. Entity Common Stock, Shares Outstanding for the quarter ending 06 May 2025 was 22,470,239.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Innovation1 Biotech Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 22,470,239 06 May 2025 10-Q 06 May 2025 2024 Q2
Q4 2024 22,470,239 0 0% 27 Jan 2025 10-Q 27 Jan 2025 2023 Q1
Q4 2023 22,470,239 +2,450,000 +12% 12 Jan 2024 10-K 17 Jan 2024 2023 FY
Q3 2023 20,470,239 12 Sep 2023 10-Q 13 Sep 2023 2023 Q3
Q2 2023 20,470,239 +450,000 +2.2% 30 May 2023 10-Q 30 May 2023 2023 Q2
Q4 2022 20,020,239 0 0% 17 Jan 2023 10-Q 17 Jan 2023 2023 Q1
Q2 2022 20,020,239 +19,831,623 +10514% 14 Jul 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 20,020,239 +19,831,623 +10514% 14 Apr 2022 10-Q 15 Apr 2022 2022 Q2
Q4 2021 20,020,239 +19,833,045 +10595% 19 Jan 2022 10-Q/A 01 Feb 2022 2022 Q1
Q2 2021 188,616 -57,448,104 -100% 13 Jul 2021 10-Q 13 Jul 2021 2021 Q3
Q1 2021 188,616 -57,448,104 -100% 14 Apr 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 187,194 -135,322,026 -100% 13 Jan 2021 10-Q 13 Jan 2021 2021 Q1
Q2 2020 57,636,720 -77,193,931 -57% 17 Jul 2020 10-Q 20 Jul 2020 2020 Q3
Q1 2020 57,636,720 -77,193,931 -57% 16 Apr 2020 10-Q 20 Apr 2020 2020 Q2
Q4 2019 135,509,220 +2,871,720 +2.2% 17 Jan 2020 10-Q 21 Jan 2020 2020 Q1
Q2 2019 134,830,651 +1,944,580 +1.5% 17 Jul 2019 10-Q 18 Jul 2019 2019 Q3
Q1 2019 134,830,651 +1,944,580 +1.5% 10 Apr 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 132,637,500 0 0% 14 Jan 2019 10-Q 18 Jan 2019 2019 Q1
Q2 2018 132,886,071 +80,248,571 +152% 18 Jul 2018 10-Q 23 Jul 2018 2018 Q3
Q1 2018 132,886,071 +80,248,571 +152% 12 Apr 2018 10-Q 23 Apr 2018 2018 Q2
Q4 2017 132,637,500 +80,000,000 +152% 12 Dec 2017 10-K/A 19 Jan 2018 2017 FY
Q2 2017 52,637,500 0 0% 31 May 2017 10-Q 24 Jul 2017 2017 Q3
Q1 2017 52,637,500 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 52,637,500 +47,637,500 +953% 30 Nov 2016 10-Q 17 Jan 2017 2017 Q1
Q3 2016 52,637,500 22 Sep 2016 10-Q 26 Sep 2016 2016 Q2
Q2 2016 52,637,500 31 May 2016 10-Q 07 Oct 2016 2016 Q3
Q4 2015 5,000,000 30 Nov 2015 10-Q 12 Feb 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.